§ 10–431
Statutes in effect as of October 1, 2026.
Md. Code Ann., Econ. Dev. § 10-431 (2026)
Title 10. Statewide Development Resources and Revenue Authorities
Subtitle 4. Maryland Technology Development Corporation
§ 10–431LinkCopy Citation
(a)
There is a Stem Cell Research Commission.
(b)
The Commission is an independent commission that functions in the Corporation.
(c)
The Commission consists of the following members:
(1)
the Attorney General or the Attorney General’s designee;
(2)
three patient advocates, one appointed by the Governor, one appointed by the President of the Senate, and one appointed by the Speaker of the House of Delegates;
(3)
three individuals with experience in biotechnology, one appointed by the Governor, one appointed by the President of the Senate, and one appointed by the Speaker of the House of Delegates;
(4)
two individuals who work as scientists for the University System of Maryland and do not engage in stem cell research, appointed by the University System of Maryland;
(5)
two individuals who work as scientists for the Johns Hopkins University and do not engage in stem cell research, appointed by the Johns Hopkins University;
(6)
two bioethicists, one appointed by the University System of Maryland and one appointed by the Johns Hopkins University; and
(7)
two individuals with expertise in the field of biomedical ethics as it relates to religion, appointed by the Governor.
(d)
(1)
The term of an appointed member is 2 years.
(2)
The terms of the appointed members are staggered as required by the terms provided for members on October 1, 2008.
(3)
At the end of a term, an appointed member continues to serve until a successor is appointed and qualifies.
(4)
An appointed member may not serve more than three consecutive full terms.
(5)
An appointed member who is appointed after a term has begun serves only for the rest of the term and until a successor is appointed and qualifies.
(e)
Each member of the Commission shall disclose to the State Commission on Ethics whether the member is employed by or has a financial interest in an entity that may apply to conduct State–funded stem cell research.
(f)
The members of the Commission shall elect a chair from among the appointed members of the Commission.
(g)
A majority of the full authorized membership of the Commission is a quorum.
(h)
The Commission shall meet at least twice a year.
(i)
A member of the Commission:
(1)
may not receive compensation as a member of the Commission; but
(2)
is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(j)
The Commission may employ a staff, including contractual staff, in accordance with the State budget.